Last reviewed · How we verify
Zolyse (CHYMOTRYPSIN)
At a glance
| Generic name | CHYMOTRYPSIN |
|---|---|
| Sponsor | Novartis |
| Therapeutic area | Other |
| Phase | FDA-approved |
| First approval | 1959 |
Approved indications
- Cataract surgery
Common side effects
Key clinical trials
- Imaging Biomarkers of Pancreatic Function and Disease (PHASE4)
- An Open Label Study of CM-AT for the Treatment of Children With Autism (PHASE3)
- The Effect of Supplementary Foods Containing Trypsin, Chymotrypsin and Serratia Peptidase on Healing After Impacted Wisdom Tooth Surgery (NA)
- The Cancer of the Pancreas Screening-5 CAPS5)Study (PHASE3)
- Assessment of Different Medications in Modifying the Efficacy of Anesthesia in Mandibular Molars With Acute Irreversible Pulpitis (PHASE4)
- Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns (PHASE2)
- Manual Therapy and Kinesio Taping on Temporomandibular Joint Dysfunction Following Oral Surgeries (NA)
- Efficacy and Safety of OsrhCT and Dimethicone Emulsion Before Upper Endoscopy on Visualization of the Gastric Mucosa. (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |